Acquired hypothalamic obesity Acquired hypothalamic obesity (HO) is a rare, severe form of secondary obesity resulting from structural or functional damage to the hypothalamus, typically after craniopharyngioma, suprasellar tumors, neurosurgery, or radiotherapy
These were tested first in the statistical testing hierarchy, followed by the confirmatory secondary endpoints, which were tested in the following order: achievement of weight loss of at least 10% or 15% at week 104
Apart from studies focused on its antioxidant activity, Epithalon has also been studied for its potential to activate an enzyme called telomerase in cell culture assays
Typical daily range: 100200 mg subcutaneously (gradual titration recommended)
Treatment Options a Clinician May Discuss Topical Minoxidil Topical minoxidil is a medication used for certain hair loss patterns